| Tau PTM profiles identify patient heterogeneity and stages of Alzheimer’s disease H Wesseling*, W Mair*, M Kumar, CN Schlaffner, S Tang, P Beerepoot, ... Cell 183 (6), 1699-1713. e13, 2020 | 457 | 2020 |
| Posttranslational modifications mediate the structural diversity of tauopathy strains T Arakhamia, CE Lee, Y Carlomagno, M Kumar, DM Duong, H Wesseling, ... Cell 180 (4), 633-644. e12, 2020 | 349 | 2020 |
| Cell-type-specific profiling of alternative translation identifies regulated protein isoform variation in the mouse brain D Sapkota, AM Lake, W Yang, C Yang, H Wesseling, A Guise, C Uncu, ... Cell reports 26 (3), 594-607. e7, 2019 | 62 | 2019 |
| Proteomic enrichment analysis of psychotic and affective disorders reveals common signatures in presynaptic glutamatergic signaling and energy metabolism MG Gottschalk*, H Wesseling*, PC Guest, S Bahn International Journal of Neuropsychopharmacology 18 (2), pyu019, 2015 | 60 | 2015 |
| Targeted multiplexed selected reaction monitoring analysis evaluates protein expression changes of molecular risk factors for major psychiatric disorders H Wesseling, MG Gottschalk, S Bahn International Journal of Neuropsychopharmacology 18 (1), pyu015, 2015 | 56 | 2015 |
| A combined metabonomic and proteomic approach identifies frontal cortex changes in a chronic phencyclidine rat model in relation to human schizophrenia brain pathology H Wesseling, MK Chan, TM Tsang, A Ernst, F Peters, PC Guest, E Holmes, ... Neuropsychopharmacology 38 (12), 2532-2544, 2013 | 55 | 2013 |
| Integrative proteomic analysis of the NMDA NR1 knockdown mouse model reveals effects on central and peripheral pathways associated with schizophrenia and autism spectrum disorders H Wesseling, PC Guest, CM Lee, EHF Wong, H Rahmoune, S Bahn Molecular autism 5, 1-17, 2014 | 49 | 2014 |
| Exopolyphosphatases PPX1 and PPX2 from Corynebacterium glutamicum SN Lindner*, S Knebel*, H Wesseling*, SM Schoberth, VF Wendisch Applied and environmental microbiology 75 (10), 3161-3170, 2009 | 45 | 2009 |
| A targeted multiplexed proteomic investigation identifies ketamine-induced changes in immune markers in rat serum and expression changes in protein kinases/phosphatases in rat … H Wesseling, H Rahmoune, M Tricklebank, PC Guest, S Bahn Journal of Proteome Research 14 (1), 411-421, 2015 | 38 | 2015 |
| Behavioral and molecular biomarkers in translational animal models for neuropsychiatric disorders Z Sarnyai, M Alsaif, S Bahn, A Ernst, PC Guest, E Hradetzky, W Kluge, ... International review of neurobiology 101, 203-238, 2011 | 36 | 2011 |
| Chemogenomic analysis reveals key role for lysine acetylation in regulating Arc stability J Lalonde, SA Reis, S Sivakumaran, CS Holland, H Wesseling, JF Sauld, ... Nature communications 8 (1), 1659, 2017 | 28 | 2017 |
| Effects of olanzapine on serum protein phosphorylation patterns in patients with schizophrenia JA Jaros, H Rahmoune, H Wesseling, FM Leweke, S Ozcan, PC Guest, ... PROTEOMICS–Clinical Applications 9 (9-10), 907-916, 2015 | 28 | 2015 |
| Posttranslational modifications mediate the structural diversity of tauopathy strains T Arakhamia, CE Lee, Y Carlomagno, M Kumar, DM Duong, H Wesseling, ... Cell 184 (25), 6207-6210, 2021 | 27 | 2021 |
| System-based proteomic and metabonomic analysis of the Df (16) A+/− mouse identifies potential miR-185 targets and molecular pathway alterations H Wesseling, B Xu, EJ Want, E Holmes, PC Guest, M Karayiorgou, ... Molecular psychiatry 22 (3), 384-395, 2017 | 25 | 2017 |
| Fetal regional brain protein signature in FASD rat model KL Davis-Anderson*, H Wesseling*, LM Siebert, ER Lunde-Young, ... Reproductive Toxicology 76, 84-92, 2018 | 23 | 2018 |
| A brain proteomic investigation of rapamycin effects in the Tsc1 +/− mouse model H Wesseling, Y Elgersma, S Bahn Molecular Autism 8, 1-12, 2017 | 22 | 2017 |
| Hippocampal proteomic and metabonomic abnormalities in neurotransmission, oxidative stress, and apoptotic pathways in a chronic phencyclidine rat model H Wesseling, EJ Want, PC Guest, H Rahmoune, E Holmes, S Bahn Journal of Proteome Research 14 (8), 3174-3187, 2015 | 17 | 2015 |
| Proteomic systems evaluation of the molecular validity of preclinical psychosis models compared to schizophrenia brain pathology DA Cox, MG Gottschalk, H Wesseling, A Ernst, JD Cooper, S Bahn Schizophrenia research 177 (1-3), 98-107, 2016 | 15 | 2016 |
| The need for phosphoproteomic approaches in psychiatric research D Martins-de-Souza, PC Guest, N Vanattou-Saifoudine, H Wesseling, ... PERGAMON-ELSEVIER SCIENCE LTD, 2011 | 15 | 2011 |
| Technological advances for deciphering the complexity of psychiatric disorders: merging proteomics with cell biology H Wesseling, PC Guest, SG Lago, S Bahn International Journal of Neuropsychopharmacology 17 (8), 1327-1341, 2014 | 14 | 2014 |
